How Many States Have a Black Market HIV Drug Problem? Interchange 2014

Since 2006, HIV positive patients in 6 states have been exposed to black market HIV/AIDS medication. There have been 6 incidents in New York alone, along with other incidents in California, Florida, New Hampshire, New Jersey and Rhode Island.

In SAFEMEDICINES’ report Black Market HIV/AIDS Drugs in the News 2006-2013, learn how dishonest drug sellers are exploiting HIV/AIDS sufferers in the United States.

 

 

 

To find out more about black market medications infiltrating the secure U.S. drug supply chain,

AGENDA 

7:30 a.m. – 8:30 a.m. Pre-conference breakfast, sponsor table browsing and networking.

8:30 a.m. – 8:40 a.m. Conference opener

• Introduction – Scott LaGanga, Executive Director Partnership for Safe Medicines; Senior Vice President, Public Affairs – Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)

8:40 a.m. – 9:10 a.m. Original Research

• Dr. Marv Shepherd, Director, Center for Pharmacoeconomic Studies
  College of Pharmacy, University of Texas-Austin
• After Counterfeit Avastin – What have we learned and what can be done
  Dr. Tim Mackey, Assistant Professor, UCSD School of Medicine
  Associate Director, MAS Program in Health Policy and Law
  Director, Global Health Policy Institute

9:10 a.m. – 10:25 a.m. Panel 1: The Global Perspective – What are the global issues of counterfeit, substandard and non-FDA approved drugs that impact American patients?

• Moderator: Tom Kubic, President and CEO, Pharmaceutical Security Institute

Panelists:

• Gillian Buckley, Program Officer, Institute of Medicine
• Jim Dahl, Assistant Director of the FDA’s Office of Criminal Investigations (OCI) (retired)
• Samantha Gompel, IPM Communications Manager at the World Customs Organization
• Philip Walsky, Acting Director, FDA-OCI

10:25 a.m. – 10:40 a.m. Networking Break

10:40 a.m. – 11.55 a.m. Panel 2: Patient safety and criminal prosecutions in the U.S.

• Moderator: Linda I. Marks, Senior Litigation Counsel, Consumer Protection Branch, Department of Justice

Panelists:

• Lindsay Androski Kelly, Assistant U.S. Attorney
• Jaime Pena, Assistant U.S. Attorney
• TBD

11:55 a.m. – 12:55 p.m. Networking Lunch

12:55 p.m. – 1:05 p.m. Pre-Panel Presentation (downstairs) PSM India

• Bejon Misra, Founder, Partnership for Safe Medicines India
• Madame LiHong Gu, Partnership for Safe Medicines China

1:05 p.m. – 2:20 p.m. Panel 3: The Impacts of Fake Online Pharmacies on Patient Safety

• Moderator: Special Agent Daniel Burke, Senior Operations Manager in Charge of Cybercrime Investigations for the Office of Criminal Investigations

Panelists:

• Libby Baney, Executive Director, Alliance for Safe Online Pharmacies
• Todd Brown, Executive Director, Massachusetts Independent Pharmacists Association
• Kenneth “Mac” McCall, President, Maine Pharmacy Association

2:20 p.m. – 2:50 p.m. Panel 4: How the Black Market Impacts Patients

• Moderator: Jim Dahl

Panelists:

• Kimberly New, National Association of Drug Diversion Investigators
• Gaurvika Nayyar, Program Manager for Asia at United States Pharmacopeia’s Promoting the Quality of Medicines Program
• Eric Sampson, Advisor to the CDC Foundation

2:50 p.m. – 3:05 p.m. Mid Afternoon Break

3:05 p.m. – 3:35 p.m. Keynote

• Jim Hood, Attorney General, State of Mississippi

3:35 p.m. – 4:15 p.m. Keynote

• Howard Sklamberg, FDA Deputy Commissioner

4:15 p.m. – 4:17 p.m. Closing Remarks, Marv Shepherd

4:17 p.m. – 5:15 p.m. Reception